Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients
NCT01897051
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
140
Enrollment
OTHER
Sponsor class
Conditions
Liver Cirrhosis
Portal Hypertension
Interventions
DRUG:
Rifaximin + propranolol
DRUG:
Propranolol + Placebo
Sponsor
Yonsei University